P/E ratio for Allscripts (MDRX)
P/E ratio as of September 2023 (TTM): 26.8
According to Allscripts's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.76. At the end of 2021 the company had a P/E ratio of 17.1.
P/E ratio history for Allscripts from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 17.1 | |
| 2019 | -9.01 | -297.19% |
| 2018 | 4.57 | -134.23% |
| 2017 | -13.3 | -81.7% |
| 2016 | -72.9 | -95.26% |
| 2015 | < -1000 | 4356.23% |
| 2014 | -34.5 | 31.71% |
| 2013 | -26.2 | -94.44% |
| 2012 | -471 | |
| 2008 | 165 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Cerner CERN | 47.5 | 77.35% | 🇺🇸 USA |
 General Electric GE | 13.9 | -48.17% | 🇺🇸 USA |
 Xerox XRX | -9.42 | -135.19% | 🇺🇸 USA |
 McKesson MCK | 16.4 | -38.82% | 🇺🇸 USA |
 Omnicell
OMCL | -88.8 | -431.71% | 🇺🇸 USA |
 Nuance Communications
NUAN | N/A | N/A | 🇺🇸 USA |
 Computer Programs and Systems CPSI | 48.1 | 79.83% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.